Facts and figures

General information

• Irish office: 3/4 Upper Pembroke Street, Dublin 2

• Global headquarters: Bagsværd, Denmark

• Irish workforce: 24 employees

• Global workforce: More than 31,300 employees

• International production facilities in seven countries

• Affiliates or offices in 74 countries

Product areas

• Diabetes care
• Hormone replacement therapy (HRT)
• Haemostasis management
• Growth hormone therapy

Global financial information

Q1 sales* 15,693
Annual sales** 60,776 (See Annual Report for more information) 

Sales by business segment* 
Diabetes care 11,808
Biopharmaceuticals 3,885
 
Sales by region* 
Europe 4,595
North America 6,035
International Operations 2,203
China 1,376
Japan & Korea 1,484
 
* million Danish kroner, Q1 results 2011
** million Danish kroner, full year results 2010 

_{Back to top
IR/WB/0711/0019
The Apis bull logo is a registered trademark of Novo Nordisk A/S}